In December 2019, an outbreak of severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) infection occurred in Wuhan, Hubei Province, China and spread across China and beyond. On February 12, 2020, WHO officially named the disease caused by the novel coronavirus as Coronavirus Disease 2019 (COVID-19). Since most COVID-19 infected patients were diagnosed with pneumonia and characteristic CT imaging patterns, radiological examinations have become vital in early diagnosis and assessment of disease course. To date, CT findings have been recommended as major evidence for clinical diagnosis of COVID-19 in Hubei, China. This review focuses on the etiology, epidemiology, and clinical symptoms of COVID-19, while highlighting the role of chest CT in prevention and disease control.  

Submit your work at https://www.scitechnol.com/submission/ or send an e-mail attachment to the Editorial Office or pharmasci@scitecjournals.com 

Best Regards,
Editorial Assistant
Journal of Pharmaceutical Sciences & Emerging Drugs
E-mail: editor.jpsed@scitechnol.com 
What’sapp No.: +1-579-679-8957